Updated COVID-19 Treatment Guidelines

Mary Madison, RN, RAC-CT, CDP 
Clinical Consultant – Briggs Healthcare

The National Institute of Health (NIH) posted What’s New in the Guidelines on May 31, 2022. Major revisions in May include:

  • Critical Care for Children
  • Antithrombotic Therapy in Patients with COVID-19
  • Critical Care for Adults
  • Corticosteroids
  • Colchicine
  • Special Considerations in Adults and Children with Cancer
  • Special Considerations in Solid Organ Transplant, Hematopoietic Stem Cell Transplant and Cellular Immunotherapy Candidates, Donors and Recipients
  • Ritonavir-Boosted Nirmatrelvir (Paxlovid)
  • Drug-Drug Interactions between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications
  • Prioritization of Anti-SARS-CoV-2 Therapies for the Treatment and Prevention of COVID-19 When There Are Logistical or Supply Constraints

The Full Guidelines, downloaded from https://www.covid19treatmentguidelines.nih.gov on June 1, 2022, are found here.